This compound is a pharmaceutical intermediate featuring a 5-azaspiro[2. 4]heptane core linked to a brominated difluorofluorene-imidazole moiety.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1441670-89-8
(6S)-6-[5-(7-Bromo-9,9-difluoro-9H-fluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylic acid phenylmethyl ester
pharmaceutical intermediate
1H-1,2,4-Triazole-1-carboxamidine hydrochloride
pharmaceutical intermediate
(2R,5S)-5-(4-Amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester
pharmaceutical intermediate
9-(4-Acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine
pharmaceutical intermediate
2-amino-6-chloropurine
pharmaceutical intermediate
Potassium (S)-5-(tert-butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylate
pharmaceutical intermediate
1-Boc-4-(aminomethyl)piperidine
pharmaceutical intermediate
4-Methylidenepiperidine--hydrogen chloride (1/1)
pharmaceutical intermediate
tert-butyl (6S)-6-[5-(7-bromo-9,9-difluorofluoren-2-yl)-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane-5-carboxylate
CZEZIZZCMWUQHO-QFIPXVFZSA-N
CC(C)(C)OC(=O)N1CC2(CC2)C[C@H]1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)Br
—